Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMX-010 in Rosacea
NCT03756389Phase 2Suspended
- Sponsor
- BioMimetix
- Start
- Jan 2018
- Primary completion
- Sep 2024
- Countries
- 1
01
Overview
A Phase 2 trial of BMX-010 in rosacea, sponsored by BioMimetix. Started Jan 2018; status: suspended.
02
Drugs
BMX-010
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT03756389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03756389.